courtlistener_docket
3 records
ABBVIE INC. v. KENNEDY
2026-04-08
Federal docket 1:26-cv-01190 (dcd); matched party 'ABBVIE INC.'
View Source
Gil v. AbbVie Inc.
2026-03-30
Federal docket 1:26-cv-22163 (flsd); matched party 'AbbVie Inc.'
View Source
AbbVie Inc v. Brown
2026-03-25
Federal docket 2:26-cv-01018 (wawd); matched party 'AbbVie Inc'
View Source
EPA (Environmental Protection Agency)
1 records
epa_echo
1 records
fda
19 records
FDA Drug Recall: Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment
2024-10-02
Class II — Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
View Source
FDA Drug Recall: Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Oi
2024-10-02
Class II — Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
View Source
FDA Drug Recall: Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle,
2023-11-15
Class III — Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
View Source
FDA Drug Recall: Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by:
2018-02-07
Class III — Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.
View Source
FDA Drug Recall: AndroGel (testosterone gel) 1.62%, 40.5mg in 2.5g aluminum foil packet, 30 Packe
2017-11-01
Class III — Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
View Source
FDA Drug Recall: AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testoste
2017-11-01
Class III — Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
View Source
FDA Device Recall: AbbVie PEG, PEG Kit 15FR, FOR ENTERAL USE ONLY, STERILE, Rx Only.
2017-06-07
Class II — PEG kits have the potential for one of the following defects: missing components, duplicate components or missing label/Instructions for Use, which includes expiry information.
View Source
FDA Device Recall: AbbVie PEG, PEG Kit 20FR, FOR ENTERAL USE ONLY, STERILE, Rx Only.
2017-06-07
Class II recall by AbbVie Inc.
View Source
FDA Device Recall: AbbVie PEG, PEG Kit 15FR, FOR ENTERAL USE ONLY, STERILE, Rx Only.
2017-06-07
Class II — PEG kits have the potential for one of the following defects: missing components, duplicate components or missing label/Instructions for Use, which includes expiry information.
View Source
FDA Drug Recall: Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL
2017-03-08
Class II — Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing...
View Source
FDA Device Recall: AbbVie PEG Kit 20 FR
2016-12-28
Class II — AbbVie is issuing an urgent field correction notification due to an increased number of reports of disconnections of the AbbVie 20FR PEG tube from the Y-connectors.
View Source
FDA Drug Recall: Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie
2016-04-27
Class III — Failed Content Uniformity Specifications
View Source
FDA Drug Recall: CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Caps
2014-10-08
Class II — Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
View Source
FDA Drug Recall: Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administratio
2014-05-07
Class II — Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
View Source
FDA Drug Recall: Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administratio
2014-05-07
Class II — Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.
View Source
FDA Drug Recall: Lupron Depot (leuprolide acetate for depot suspension) Single Dose Administratio
2014-05-07
Class II — Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
View Source
FDA Drug Recall: LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension) Single Dose Administr
2014-05-07
Class II — Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
View Source
FDA Drug Recall: Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administratio
2014-05-07
Class II — Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
View Source
FDA Drug Recall: Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Hal
2013-08-28
Class III — Labeling: Incorrect Package Insert; product packaged with outdated version of the insert
View Source
fda_adverse
1 records
ftc_enforcement
2 records
AbbVie Inc., et al.
2021-07-30
FTC live enforcement action FY2021; matched respondent 'AbbVie Inc.'
View Source
AbbVie Inc. and Allergan plc, In the Matter of
2020-09-04
FTC live enforcement action FY2020; matched respondent 'AbbVie Inc.'
View Source
lobbying
11 records
Lobbying Firm: ABBVIE, INC.
Registered lobbying firm — Washington, DC — Biopharmaceutical company
View Source
Lobbying Client: ABBVIE INC.
Lobbied by CHECKMATE GOVERNMENT RELATIONS — Medical solution provider
View Source
Lobbying Client: ABBVIE, INC.
Lobbied by WILLIAMS AND JENSEN, PLLC — Biopharmaceutical company
View Source
Lobbying Client: ABBVIE INC.
Lobbied by CORNERSTONE GOVERNMENT AFFAIRS, INC. — Biopharmaceutical company
View Source
Lobbying Client: ABBVIE INC.
Lobbied by MARSHALL & POPP, LLC — Biopharmaceutical company.
View Source
Lobbying Client: ABBVIE, INC.
Lobbied by BAKER & HOSTETLER LLP — Pharmaceutical researcher and manufacturer
View Source
Lobbying Client: ABBVIE INC.
Lobbied by CORNERSTONE GOVERNMENT AFFAIRS, INC. — Biopharmaceutical company
View Source
Lobbying Client: ABBVIE INC.
Lobbied by MARSHALL & POPP, LLC — Biopharmaceutical company.
View Source
Lobbying Client: ABBVIE INC.
Lobbied by MARSHALL & POPP, LLC — Biopharmaceutical company.
View Source
Lobbying Client: ABBVIE, INC.
Lobbied by BAKER & HOSTETLER LLP — Pharmaceutical researcher and manufacturer
View Source
ny_corps
1 records
NY Corp: ABBVIE INC.
2012-08-07
FOREIGN BUSINESS CORPORATION | County: Monroe | Jurisdiction: Delaware
View Source
SEC EDGAR
1 records
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.